Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Bladder Cancer.

Zechao LuFucai TangZhichen LiYongchang LaiZeguang LuJiahao ZhangZhicheng TangWanyan CaiZhaohui He

Published in: Disease markers (2022)

Therefore, this prognostic risk model is based on the level of pyroptotic lncRNAs, which is conducive to individualized assessment of the risk of patients and provides a reference for clinical treatment. This will also help provide insights into the prognosis and treatment of bladder cancer.

Keyphrases

end stage renal disease
ejection fraction
peritoneal dialysis
combination therapy
patient reported outcomes
transcription factor
replacement therapy
smoking cessation